Session » Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis
-
Abstract Number: 1023
Fracture Risk Reduction with Romosozumab: Results of a Phase 3 Study in Postmenopausal Women with Osteoporosis
-
Abstract Number: 1025
Assessment of the Effects of Switching Bisphosphonates to Denosumab or Daily Teriparatide in Patients with Rheumatoid Arthritis
-
Abstract Number: 1026
Morphea-like Skin Lesions Reported in the Phase 3 Long-Term Odanacatib Fracture Trial and Extension in Postmenopausal Women with Osteoporosis